Masterflex SE Reports Strong Second Quarter Growth
Masterflex SE has displayed a significant resurgence in its business performance during the second quarter of the year, following a rather subdued start. According to SMC-Research, this growth is particularly attributed to the positive developments of two major growth initiatives, which are expected to contribute to the company's revenue in the latter half of the year. Despite a slight reduction in profit estimates for 2026, analysts remain confident in a strong earnings rebound for the upcoming year. SMC-Research has maintained its price target for the stock at €19.50 and affirmed its 'Buy' recommendation.
In the second quarter, Masterflex achieved a revenue increase of 4.2%, bringing total sales to €26.9 million. This has led to a cumulative revenue of €54.3 million for the first half of the year, surpassing the previous year's figure of €53.4 million by 1.7%. The company's EBIT also showed modest growth, reaching €7.9 million compared to €7.8 million the prior year, which allows the EBIT margin to hold steady at an impressive 14.5%. Thanks to improved financial results and a slightly lower tax rate, net profit surged by nearly 8% to €5.3 million.
Future Prospects and Company Outlook
Looking ahead, SMC-Research emphasizes that the ongoing progress of Masterflex's two significant growth initiatives—the establishment of a new production facility in Morocco and the preparation for the delivery of a major development and framework contract—are more crucial than the Q2 figures. These initiatives are expected to begin impacting revenues in the latter part of the second half of the year. In the case of Morocco, initial results may not show immediate revenue contributions pending customer certifications.
Masterflex has reaffirmed its full-year guidance, aiming for revenues between €103 million and €108 million and an EBIT of €13 million to €16 million. SMC-Research has indicated confidence that the company will at least reach the mid-point of this revenue range, supported by a growing order backlog which increased by €2 million to €21.8 million since the beginning of the year. July has reportedly continued this positive trend, contributing to further revenue growth and an increase in the order backlog.
Despite maintaining the revenue estimate for the current year at €106.2 million following a solid first half, SMC-Research has slightly adjusted the expense structure to reflect the increased personnel costs. Consequently, the EBIT estimate has been lowered to €13.3 million from a previous €14.1 million, which now aligns with the lower end of the company’s guidance. Nevertheless, analysts remain optimistic about a significant earnings surge next year when both initiatives will contribute fully. They also maintain a target EBIT margin of 15.7 percent.
Moreover, there is additional potential that SMC-Research's model does not yet account for, stemming from Masterflex's acquisition strategy, which aims to add €50 million towards the targeted revenue of €200 million by 2030. While the completion of an initial transaction, announced in spring, may face delays until the third quarter, the company expresses confidence in making its first acquisition move by the end of the year. However, Masterflex also acknowledges the uncertainties involved in the acquisition process. SMC-Research has no doubts regarding the financial viability of such a step, as evidenced by a robust equity ratio of 73.3% and a significantly reduced net financial debt of €4.3 million, indicating a strong balance sheet.
Based on the updated model, SMC-Research's target price remains unchanged at €19.50, signaling more than a one-third upside potential for the stock. Therefore, SMC-Research reiterates its 'Buy' rating, highlighting that Masterflex not only presents an attractive valuation but also boasts an excellent balance sheet and reliable corporate governance, which is expected to remain intact even after the relocation of shareholdings to major shareholder J.F. Müller & Sohn.
As reported by live.deutsche-boerse.com.